Yu, Y., Li, J., Gan, W., Chen, J., Li, L. (2025). Real-world study of anti–PD-1 combined with regorafenib and raltitrexed as third-line therapy in colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15510